References
- Opie LH, Horowitz J. Beta-blocking agents. In: Opie LH, Gersh BJ, editors. Drugs for the heart. 7th ed. Philadelphia: Elsevier Saunders, 2009: p.1–37.
- Stout SM, Nielsen J, Welage LS, et al. Influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine. J Clin Pharmacol. 2011:51(3):389–396.
- FDA recommends against the continued use of propoxyphene. US Food and Drug Administration, 2010.
- Baudhuin LM, Miller WL, Train L, et al. Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure. Am J Cardiol. 2010:106(3):402–408.
- Hypertension: the clinical management of primary hypertension in adults. National Institute for Health and Clinical Excellence (NICE) clinical guidelines: methods, evidence and recommendations, 2011.
- Opie LH. Calcium channel blockers (calcium antagonists). In: Opie LH, Gersh BJ, editors. Drugs for the heart. 7th ed. Philadelphia: Elsevier Saunders, 2009; p. 59–87.
- Egan A, Colman E. Weighing the benefits of high-dose simvastatin against the risk of myopathy. N Engl J Med. 2011:365(4):285–287.
- Dorsch MP, Gillespie BW, Erickson SR, et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. 2011: 57(4):689–694.
- Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008:358(18):1887–1898.
- Opie LH, Kaplan N. Drugs for the heart. 7th ed. Philadelphia: Elsevier Saunders, 2009; p. 88–111.
- Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999:341(10);709–717.
- Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003:348(14);1309–1321.
- Beilin LJ. Non-steroidal anti-inflammatory drugs and antihypertensive drug therapy. J Hypertens. 2002:20(5):849–850.
- Reddy P, Ellington D, Zhu Y, et al. Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily. Br J Clin Pharmacol. 2011;72(3):434–441.